HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!
|
|
- Georgina Henry
- 5 years ago
- Views:
Transcription
1 Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours Page 1 of 2 Time of Arrival Loca8on Date / / Diagnosis the characteris8c features of a person with HHS are a) Hypovolaemia b) Marked hyperglycaemia (30 mmol/l or more) without significant hyperketonaemia (less than 3 mmol/l), ketonuria (2+ or less) or acidosis (H + <45 mmol/l, HCO 3 - > 15 mmol/l) c) Osmolality usually 320 mosmol/kg or more HHS AFFIX PATIENT LABEL A mixed picture of HHS and DKA may occur Aims GRADUAL normalisa<on of dehydra<on and metabolic abnormali<es 1. Reduce the serum osmolality by 3 8 mosmol/kg per hour 2. Reduce the plasma glucose by less than 5 mmol/l per hour Plasma osmolality is calculated as (2 x Na + ) + glucose + urea regular assessment is mandatory! INFORM DIABETES TEAM OF ADMISSION! 1. Immediate ac<ons 0 to 60 minutes Record 8me of arrival Assess severity (guidance note 1) including detailed volume status assessment Commence IV 0.9% Sodium Chloride - 1 litre over 1 hour (more rapid replacement may be required when SBP <90 and slower replacement considered when heart failure a concern) Only commence insulin (0.05 units/kg/hr) if significant ketonaemia (> 1 mmol/l) or ketonuria (> 2+) Check capillary blood glucose, capillary or urinary ketones, U&Es, venous blood gas, lactate, calculate osmolality (2 x Na + + glucose + urea) and FBC. Record relevant details in flow sheet (overleaf) Insert urinary catheter and monitor hourly urine output Commence prophylac8c LMWH (pa8ents are at high risk of arterial and venous thrombosis) Record es8mated water loss (guidance note 3) Other interven<ons to be considered ECG and consider cardiac monitor Record GCS score CRP MSSU IV an8bio8cs (if sepsis suspected) Blood cultures Central line Chest X- ray Record foot risk (guidance note 5) If deteriora<ng, consultant or senior physician called 2. Management 60 minutes to 6 hours Aim for gradual decline in osmolality (3 8 mosmol/kg/hr) and achieve posi8ve fluid balance of 2 3 L by 6 hours Aim to give L/hr 0.9% Sodium Chloride (depending on clinical fluid balance assessment) Measure glucose and U&Es hourly and calculate osmolality 1h 2h 3h 4h 5h 6h Adjust fluid administra8on based on clinical assessment and hourly assessment of osmolality (guidance note 2) Potassium replacement follow guidance note 4 If blood glucose falling less than 5 mmol/l check fluid balance. If posi8ve balance inadequate increase rate of 0.9% Sodium Chloride infusion. If posi8ve balance adequate start IV insulin at 0.05 units/kg/hr (or increase rate to 0.1 units/kg/hr if already running) Aim to keep glucose between mmol/l. If glucose falls below 14 mmol/l commence 10% glucose at 125 ml/hr AND CONTINUE sodium chloride solu8on Joint Bri8sh Diabetes Socie8es HHS protocol August 2012 NHS Lothian version 3 F. Gibb and S. Ritchie 01/04/2014
2 HHS pa8ent data flow chart First 12 hours Presentation After 1 hour After 2 hours After 3 hours After 4 hours Time (use 24hr clock) Mental status (AVPU) Respiratory rate SaO 2 (%) OBSERVATIONS Inspired O 2 (%) Temperature ( C) BP (mmhg) Heart rate / / / / / Hourly urine output (ml/hr) Total cumulative urine output (ml) SEWS Glucose (mmol/l) lab [L], gas [G], BM [B] Sodium (mmol/l) BIOCHEMISTRY Urea (mmol/l) Serum osmolality * (mosmol/kg) Potassium (mmol/l) Bicarbonate (mmol/l) Hydrogen ion (mmol/l) Insulin (units infused in past hour) FLUIDS & INSULIN 0.9% Saline (ml infused in past hour) 0.45% Saline (ml infused in past hour) 10% Glucose (ml infused in past hour) KCL (mmol infused in past hour) Total fluid input (litres) Fluid balance since admission (litres) Staff nurse responsible for care (initial) Doctor responsible for care (initial)! HIGHLIGHTED BOXES ARE MANDATORY! *Calculated osmolality = 2 x Na + + glucose + urea
3 HHS GOALS OF TREATMENT Aner 6 hours, begin using Care Pathway 2 but con8nue recording data in this flow chart up to 12 hours Normalise the osmolality Replace fluid and electrolyte losses Normalise blood glucose Preven8on of arterial or venous thrombosis Prevent other complica8ons (e.g. Cerebral oedema / osmo8c demyelina8on) Prevent foot ulcera8on After 5 hours After 6 hours After 7 hours After 8 hours After 9 hours After 10 hours After 11 hours After 12 hours / / / / / / / / FLOW CHART FOR NEXT 12 HOURS IS IN CARE PATHWAY 2
4 Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours Page 2 of 2 Fluid (Potassium) prescrip<on sheet FLUID VOL (ml) RATE PRINT NAME SERIAL NO TIME BEGUN POTASSIUM DOSE SIGNATURE BATCH NO (mmol) A Sodium Chloride 0.9% 500 ml 1L / hr B Sodium Chloride 0.9% 500 ml 1L / hr C D E F G H I Once Blood Glucose <14 mmol/l start Glucose 10% J Glucose 10% K Glucose 10% L Intravenous Insulin Prescrip<on TIME INSULIN RATE (units/hr) TYPE OF INSULIN PRINT NAME SIGNATURE NEW PRINCIPLES Measure or calculate osmolality (2Na+ + glucose + urea) frequently to monitor treatment response. Use IV 0.9% sodium chloride solu8on as the principle fluid to restore circula8ng volume and reverse dehydra8on. Only switch to 0.45% sodium chloride solu8on if the osmolality is not declining despite adequate posi8ve fluid balance. An ini8al rise in sodium is expected and is not in itself an indica8on for hypotonic fluids. Thereaner, the rate of fall of plasma sodium should not exceed 10 mmol/l in 24 hours. The fall in blood glucose should be no more than 5 mmol/l/hr. Low dose IV insulin (0.05 units/kg/hr) should be commenced once the blood glucose is no longer falling with IV fluids alone OR immediately if there is significant ketonaemia (3β- hydroxy butyrate greater than 1mmol/L). Assess foot risk score on admission.
5 Hyperglycaemic Hyperosmolar State Care Pathway 2 6 hours to day 3 Page 1 of 2 Time pathway started Loca8on Date / / Aims a) Ensure clinical and biochemical parameters are improving b) Con8nue IV fluid replacement (posi8ve balance of 3-6 litres by 12 hours and replacement of es8mated losses by 24 hours) c) Assess for complica8ons of treatment d) Con8nue trea8ng underlying precipitant(s) e) Avoid hypoglycaemia HHS AFFIX PATIENT LABEL 1. Management from 6 to 12 hours Aim for gradual decline in osmolality (3 8 mosmol/kg/hr) and achieve posi8ve balance of 3 6 litres by 12 hours Measure and record glucose hourly; U&Es and calculated osmolality 2 hourly. Ensure results are recorded in the data flow chart. Refer to guidance note 2 if osmolality is not falling at the desired rate. If blood glucose falling less than 5 mmol/l check fluid balance. If posi8ve balance inadequate increase rate of 0.9% Sodium Chloride infusion. If posi8ve balance adequate start IV insulin at 0.05 units/kg/hr (or increase rate to 0.1 units/kg/hr if already running) Aim to keep glucose between mmol/l. If glucose falls below 14 mmol/l commence 10% glucose at 125 ml/hr AND CONTINUE sodium chloride solu8on Adjust insulin infusion by 1 unit/hr increments or decrements to achieve desired blood glucose Potassium replacement follow guidance note 4. Assess for complica8ons and ensure senior review if pa8ent (or biochemistry) not improving 2. Management from 12 to 24 hours Aim for gradual decline in osmolality (3 8 mosmol/kg/hr) and replace es8mated fluid losses by 24 hours Review fluid balance to date and es8mate fluid deficit to be replaced in the hour period Es8mated minimum fluid loss at presenta8on (guidance note 3) litres Fluid replaced to 12 hours litres Residual volume to be replaced between hours litres Measure and record glucose hourly; U&Es and calculated osmolality 4 hourly (2 hourly if not improving) Follow guidance note 2 if osmolality is not falling at the required rate. Adjust insulin (if running) as previously described. Replace potassium as indicated in guidance note 4. Assess for complica8ons and ensure senior review if pa8ent (or biochemistry) not improving 3. Management from 24 hours to 3 days Pa8ent should be steadily recovering, beginning to eat and drink, biochemistry back to normal Ensure clinical and biochemical parameters are improving Con8nue IV fluids and variable rate insulin un8l ea8ng and drinking then convert to subcutaneous insulin Encourage mobilisa8on Daily U&Es (minimum) Remove catheter when appropriate Assess for complica8ons and sepsis Daily foot checks Con8nue LMWH un8l discharge (and possibly beyond in very high risk pa8ents) Joint Bri8sh Diabetes Socie8es HHS protocol August 2012 NHS Lothian version 3 F. Gibb and S. Ritchie 01/04/2014
6 HHS pa8ent data flow chart 13 to 24 hours After 13 hours After 14 hours After 15 hours After 16 hours After 17 hours Time (use 24hr clock) Mental status (AVPU) Respiratory rate SaO 2 (%) OBSERVATIONS Inspired O 2 (%) Temperature ( C) BP (mmhg) Heart rate / / / / / Hourly urine output (ml/hr) Total cumulative urine output (ml) SEWS Glucose (mmol/l) lab [L], gas [G], BM [B] Sodium (mmol/l) BIOCHEMISTRY Urea (mmol/l) Serum osmolality (mosmol/kg) Potassium (mmol/l) Bicarbonate (mmol/l) Hydrogen ion (mmol/l) Insulin (units infused in past hour) FLUIDS & INSULIN 0.9% Saline (ml infused in past hour) 0.45% Saline (ml infused in past hour) 10% Glucose (ml infused in past hour) KCL (mmol infused in past hour) Total fluid input (litres) Fluid balance since admission (litres) Staff nurse responsible for care (initial) Doctor responsible for care (initial)! HIGHLIGHTED BOXES ARE MANDATORY!
7 HHS GOALS OF TREATMENT Normalise the osmolality Replace fluid and electrolyte losses Normalise blood glucose Preven8on of arterial or venous thrombosis Prevent other complica8ons (e.g. Cerebral oedema / osmo8c demyelina8on) Prevent foot ulcera8on After 18 hours After 19 hours After 20 hours After 21 hours After 22 hours After 23 hours After 24 hours / / / / / / /
8 Hyperglycaemic Hyperosmolar State Care Pathway 2 From 6 hours to 3 days Page 2 of 2 Fluid (Potassium) prescrip<on sheet FLUID VOL (ml) RATE PRINT NAME SERIAL NO TIME BEGUN POTASSIUM DOSE SIGNATURE BATCH NO (mmol) A B C D E F G H I Once Blood Glucose <14 mmol/l start Glucose 10% J Glucose 10% K Glucose 10% L Intravenous Insulin Prescrip<on TIME INSULIN RATE (units/hr) TYPE OF INSULIN PRINT NAME SIGNATURE PLEASE USE SUPPLEMENTARY HHS FLUID/INSULIN CHART IF REQUIRED
9 Hyperglycaemic Hyperosmolar State Supplementary fluid / insulin prescrip8on Use this chart if no further space on Care Pathway 2 fluid prescrip8on sheet AFFIX PATIENT LABEL Fluid (Potassium) prescrip<on sheet FLUID VOL (ml) RATE PRINT NAME SERIAL NO TIME BEGUN POTASSIUM DOSE SIGNATURE BATCH NO (mmol) A B C D E F G Once Blood Glucose <14 mmol/l start Glucose 10% H Glucose 10% I Glucose 10% J K Intravenous Insulin Prescrip<on TIME INSULIN RATE (units/hr) TYPE OF INSULIN PRINT NAME SIGNATURE
10 SECTION 1. SEVERITY ASSESSMENT Hyperglycaemic Hyperosmolar State Guidance notes Pa8ents with HHS are generally very unwell on presenta8on and require regular assessment. Seek senior advice (and consider HDU review) if severity markers present or if deteriora8ng despite treatment Osmolality greater than 350 mosmol/kg Sodium greater than 160 mmol/l or H other + greater serious than co- morbidity 80 mmol/l Hypokalaemia (<3.5 mmol/l) or Hyperkalaemia (> 6mmol/L) GCS less than 12 Oxygen satura8on below 92% (if normal respiratory baseline) Systolic BP < 90 mmhg Pulse over 100 or below 60 bpm Urine output less than 0.5 ml/kg/hr Serum crea8nine >200 µmol/l Hypothermia Macrovascular event or other serious co- morbidity SECTION 2. INTERPRETING AND RESPONDING TO OSMOLALITY RESULTS If osmolality falling at the required rate of 3 8 mosmol/l con8nue 0.9% Sodium Chloride If plasma Na + increasing but osmolality declining at appropriate rate con8nue 0.9% Sodium Chloride If plasma Na + increasing AND osmolality increasing (or declining <3 mosmol/kg/hr) check fluid balance if or posi8ve other serious balance co- morbidity inadequate increase rate of 0.9% Sodium Chloride. If fluid balance adequate consider switch to 0.45% Sodium Chloride If osmolality falling at rate exceeding 8 mosmol/kg/hr consider reducing infusion rate of IV fluids and/or IV insulin (if already commenced) SECTION 3. ESTIMATED MINIMUM FLUID AND ELECTROLYTE LOSSES (AT PRESENTATION) Weight (kg) Water (litres) Sodium (mmol) Potassium (mmol) SECTION 4. POTASSIUM REPLACEMENT If potassium above 5.5 mmol/l no addi8onal KCL. or If other potassium serious between co- morbidity 3.5 and 5.5 prescribe 20 mmol/l KCL per infusion fluid. If potassium below 3.5 mmol/l seek senior advice. SECTION 5. FOOT RISK ASSESSMENT Risk category Criteria Ac8on ACTIVE Presence of active ulceration, spreading infection, critical ischaemia, gangrene or unexplained hot, red, swollen foot with or without the presence of pain. Rapid referral to Multidisciplinary Foot Team. HIGH RISK Previous ulceration or amputation or more than one risk factor present e.g. loss of sensation or signs of peripheral vascular disease with callus or deformity. Use foam heel protectors to reduce heel ulcer risk. MEDIUM RISK LOW RISK One risk factor present e.g. loss of sensation or signs of peripheral vascular disease without callus or deformity. No risk factors present e.g. no loss of sensation, no signs of peripheral vascular disease and no other risk factors. Annual podiatry input no urgent action required. Annual screening no urgent action required. Joint Bri8sh Diabetes Socie8es HHS protocol August 2012 NHS Lothian version 3 F. Gibb and S. Ritchie 01/04/2014
Country Health SA Local Health Network
Country Health SA Local Health Network Protocol (Clinical) Title: Hyperglycaemic Hyperosmolar State Management in Adults with Type 2 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor:
More informationPlease inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.
Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:
More informationCountry Health SA Local Health Network. Version control and change history
Country Health SA Local Health Network Protocol (Clinical) Title: Diabetic Ketoacidosis Management in Adults with Type 1 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor: CHSALHN,
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow June 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood Glucose
More informationGuidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group
Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group 1. Introduction 1.1 This document sets out the University Hospitals of Leicester (UHL) guidelines
More informationHyperglycaemic Emergencies GRI EDUCATION
Hyperglycaemic Emergencies GRI EDUCATION LEARNING OUTCOMES Develop and describe your system of blood gas interpretation and recognise common patterns of acid-base abnormality. Describe the pathophysiology
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow September 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood
More informationINTRAVENOUS FLUIDS PRINCIPLES
INTRAVENOUS FLUIDS PRINCIPLES Postnatal physiological weight loss is approximately 5-10% Postnatal diuresis is delayed in Respiratory Distress Syndrome (RDS) Preterm babies have limited capacity to excrete
More informationINTRAVENOUS FLUID THERAPY
INTRAVENOUS FLUID THERAPY PRINCIPLES Postnatal physiological weight loss is approximately 5 10% in first week of life Preterm neonates have more total body water and may lose 10 15% of their weight in
More informationCase TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air
Mr N is a 64year old Chinese gentleman who is a heavy drinker, still actively drinking, and chronic smoker of >40pack year history. He has a past medical history significant for Hypertension, Hyperlipidemia,
More informationCOMPLIANCE WITH THIS DOCUMENT IS MANDATORY
COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER
More informationDiabetic ketoacidosis Expiry date 2005
Diabetic ketoacidosis Expiry date 2005 PREVALENCE Diabetic ketoacidosis is defined as [D] 1 : hyperglycaemia (> 14 mmol/l) metabolic acidosis (ph < 7.35 or bicarbonate < 15 mmol/l) high anion gap (anion
More informationLynda Astbury Lead Diabetes Specialist Nurse
Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)
More informationBrief summary of the NICE guidelines December 2013
Brief summary of the NICE guidelines December 2013 Intravenous fluid therapy in adults in hospital the relevance to Emergency Department Care Applicable to patients 16 years and older receiving i.v. fluids
More informationManagement of Adult patients with Diabetic Ketoacidosis (DKA) & Hyperosmolar Non-ketotic Coma (HONK) Most current literature relevant to critical care
NAME OF DOCUMENT TYPE OF DOCUMENT Management of Adult patients with Diabetic Ketoacidosis (DKA) & Hyperosmolar Non-ketotic Coma (HONK) GUIDELINE DOCUMENT NUMBER ED CLIN GL 04 DATE OF PUBLICATION May 2013
More informationDIABETIC KETOACIDOSIS MANAGEMENT PLAN:
DIABETIC KETOACIDOSIS MANAGEMENT PLAN: 1. Assessment (weight, blood glucose level (BGL), blood pressure (BP), heart rate (HR), respiratory rate (RR), temperature, history & examination) 2. Resuscitation
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationUse this version only
Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS (DKA) Use this version only Patient Label Details Ward: Consultant: Named Nurse: Date of Admission: Date of Discharge/Transfer: ALL STAFF TO WRITE
More informationLRI Children s Hospital
LRI Children s Hospital Diabetic Ketoacidosis (DKA) Management in Children Staff relevant to: Medical & Nursing staff working within the UHL Children s Hospital. Team approval date: March 2017 Version:
More informationSIMPLY. Fluids. Dr Will Dooley
SIMPLY. Fluids Dr Will Dooley Plan Maintenance vs Resuscitation Prescribing Common Errors Calculations Drip rates Case 54 yo presents with severe diarrhoea and vomiting. How would you proceed? Assessment
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationSCENARIO. Maternal Medicine -DKA LEARNING OBJECTIVES
SCENARIO Maternal Medicine -DKA LEARNING OBJECTIVES Recognition of the of the seriously ill patient Diagnosis of DKA in pregnancy Recognition of precipitating factors for DKA Initiate emergency management
More informationDiabetic Ketoacidosis (DKA)
Diabetic Ketoacidosis (DKA) Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of submission February
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Title Title: UNDERGOING SPINAL DEFORMITY SURGERY Version: 2 Reference Number: Supersedes Supersedes: all other versions Description of Amendment(s): Revision of analgesia requirements
More informationGuidelines for the care of Children with Diabetes Mellitus undergoing Surgery
Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery Background Surgery places physical and emotional stress on the body. This, alongside new surroundings, parental anxiety and
More informationInpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham
Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham A Case of Inpatient Diabetes 22.09.15 Mrs DE Ketosis-prone T2DM on bd Humulin-I, Metformin and Linagliptin
More informationIntegrated Care Pathway (ICP) for Children and Young People with Diabetic Keto-acidosis (DKA)
Shared Guidelines Group: Vijith Puthi, John Hyde, Nisha Nathwani, Nadeem Abdullah, Vipan Datta, R. Misquith Integrated Care Pathway (ICP) for Children and Young People with Diabetic Keto-acidosis (DKA)
More informationPediatric Intensive Care Unit (PICU) Pediatric Diabetic Ketoacidosis (DKA) Admission Order Set
Discontinue all previous orders Weight: kg DKA admit order set is for initial management Ongoing management required based on frequent reassessment of TFI, fluid balance and lab results. Admit to PICU
More informationDiabetic Keto Acidosis
Diabetic Keto Acidosis Dr Jeremy Turner MRCP D.Phil Consultant Physician, Elsie Bertram Diabetes Centre Norfolk and Norwich University Hospital What is the definition of DKA? Diabetic ketoacidosis is defined
More informationPediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set
Admitting MRP: Pediatrics: Dr. / Dr. on call to cover until 08:00 am Service: Medicine Team 1 Medicine Team 2 Medical subspecialty Diagnosis: Diabetic Ketoacidosis (DKA) Estimated length of stay Less than
More informationDKA Adult ICU Powerplan
DKA Adult ICU Powerplan Key Points for ED to ICU DKA power plan In addition to NS fluids and maintenance the regular insulin drip will either already be infusing from ED or needs to be initiated. Regular
More informationPage of 9 Blood Glucose Level (BGL) Blood Glucose Monitoring (BGM) Diabetic Ketoacidosis (DKA) Hyperglycaemia Hyperglycaemic Hyperosmolar (Non-ketotic
Page 1 of 9 Policies & Protocols Procedure for Management of Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycaemic State (HHS) Protocol Protocol: Objective To ensure a high standard of prompt, safe,
More informationThe Oxford AHSN Sepsis Pathway
From confusion to consensus: The Oxford AHSN Sepsis Pathway Andrew Brent Sepsis Clinical Lead, Oxford AHSN & Oxford University Hospitals NHS Foundation Trust 2013 2014 2015 2016 2017 From: The Third International
More informationGUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart)
GUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart) This guidance does not override the individual responsibility of health professionals
More informationMANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY
MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY Background Management is different in different groups of women with diabetes. Women with Type 1 Diabetes (previously
More informationJoint British Diabetes Societies Inpatient Care Group
Joint British Diabetes Societies Inpatient Care Group The Management of Diabetic Ketoacidosis in Adults Second Edition Update: September 2013 This document has been endorsed by the Intensive Care Society
More informationGuideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation
CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin
More informationThe management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes
The management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes Joint British Diabetes Societies Inpatient Care Group August 2012 Supporting, Improving, Caring August 2012 This document
More informationDiabetes (DIA) Measures Document
Diabetes (DIA) Measures Document DIA Version: 2.1 - covering patients discharged between 01/07/2016 and present. Programme Lead: Liz Kanwar Clinical Lead: Dr Aftab Ahmad Number of Measures In Clinical
More informationNephrology. 3 rd Year Revision Session 06/05/17 Cathal Hannan
Nephrology 3 rd Year Revision Session 06/05/17 Cathal Hannan Aims Acute Kidney Injury-recognition and management Sample OSCE Station Clinically relevant renal physiology Aetiology of Chronic Kidney Disease
More informationReducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway
Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway Dr Alex Williams, Oncology Specialty Doctor. Cheltenham General Hospital Oncology Centre
More informationACUTE KIDNEY INJURY FOCUS ON OBSTETRICS DONNA HIGGINS, CLINICAL NURSE EDUCATOR, NORTHERN LINCOLNSHIRE HOSPITALS NHS FOUNDATION TRUST
ACUTE KIDNEY INJURY FOCUS ON OBSTETRICS DONNA HIGGINS, CLINICAL NURSE EDUCATOR, NORTHERN LINCOLNSHIRE HOSPITALS NHS FOUNDATION TRUST AIMS & OBJECTIVES Review the functions of the kidney Identify renal
More informationManaging Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines
Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date
More informationBREAK 11:10-11:
1. Sepsis Tom Heaps 09:30-10:20 2. Oncological Emergencies Clare Pollard 10:20-11:10 ------------------------ BREAK 11:10-11:30 ------------------------ 3. Diabetic Ketoacidosis Tom Heaps 11:30-12:20 4.
More informationInpatient Diabetes Care
Inpatient Diabetes Care Data from the National Diabetes Inpatient Audit suggest that the number of hospital inpatients with diabetes ranges from ~10% to over 30%. This does not mean that up to 1 in 3 inpatients
More informationAcute Kidney Injury shared guidance
Acute Kidney Injury shared guidance Acute Kidney Injury (AKI) Fluid balance assessment (NICE CG 169) Assess the patient s likely fluid and electrolyte needs 1.History previous limited intake, thirst, abnormal
More informationPHARMACOLOGY AND PHARMACOKINETICS
DRUG GUIDELINE Insulin, human neutral (Actrapid ) Intravenous Infusion for SCOPE (Area): FOR USE IN: Critical Care Unit, Emergency Department and Operating Suite EXCLUSIONS: Paediatrics (seek Paediatrician
More informationISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)
Contact Details Name: Hospital Telephone: This protocol has 5 pages ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Please read carefully. Meticulous treatment is very important as there
More informationA I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol
SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH Clinical Protocol DIABETES IN PREGNANCY Diabetes; Management of GlycaemicControl in labour and in the antenatal period. Document Information
More informationAcute Kidney Injury (AKI) Undergraduate nurse education
Acute Kidney Injury (AKI) Undergraduate nurse education Year Three Developed Summer 2017 Objectives Understand Acute Kidney Injury and its relevance to patient care. Brief revision of the Anatomy and physiology
More informationDiabetic Ketoacidosis
Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized
More informationNEONATAL HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE) & COOLING THERAPY
Background NEONATAL HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE) & COOLING THERAPY A perinatal hypoxic-ischaemic insult may present with varying degrees of neonatal encephalopathy, neurological disorder and
More informationABCD guidelines for the management of hyperglycaemic emergencies in adults
ABCD guidelines for the management of hyperglycaemic emergencies in adults MW Savage*, A Kilvert, on behalf of the Association of British Clinical Diabetologists (ABCD) Introduction Diabetic emergencies
More informationSARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE
SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: DKA / HHNS PATIENTS REQUIRING INTRAVENOUS INSULIN DRIPS -ADULTS Nursing DATE: REVIEWED: PAGES: 12/14 5/18 1 of 8 RESPONSIBILITY: *RN (Renal/Diabetes/Wound
More informationManaging Acid Base and Electrolyte Disturbances with RRT
Managing Acid Base and Electrolyte Disturbances with RRT John R Prowle MA MSc MD MRCP FFICM Consultant in Intensive Care & Renal Medicine RRT for Regulation of Acid-base and Electrolyte Acid base load
More informationStaff at the Nottingham Children s Hospital. Guidelines process.
Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,
More informationDKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate
Approved by Diabetes Steering Committee, MMC, 2015 DKA/HHS Pathway Phase 1 (Adult) DKA Diagnostic Criteria (See page 3 for more details): Blood glucose >250 mg/dl, Arterial ph
More informationInsulin Tolerance Test Protocol - RNS Endocrinology
Page 1 of 7 - RNS Endocrinology Test name Insulin tolerance test. Alternate test names. Related Tests. Indication(s) Investigation of the hypothalamic pituitary axis (HPA) with regard to the release of
More informationSeptember 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart
September 14 V0.17 Aims and outcomes of session. Aim: To provide guidance on correctly completing the paediatric daily fluid prescription & balance chart. Outcomes: Demonstrate the ability to: calculate
More informationMAKING SENSE OF IT ALL AUGUST 17
MAKING SENSE OF IT ALL AUGUST 17 @SepsisUK Dr Ron Daniels B.E.M. CEO, UK Sepsis Trust CEO, Global Sepsis Alliance Special Adviser to WHO SCALE AND BURDEN @sepsisuk Dr Ron Daniels B.E.M. CEO, UK Sepsis
More informationPAEDIATRIC FLUIDS RCH DEHYDRATION
PAEDIATRIC FLUIDS RCH DEHYDRATION AIMS Understand normal fluids electrolyte requirements/ maintenance Understand how to assess DEHYDRATION in children Understand the difference between DEHYDRATION and
More informationINTRAVENOUS FLUID THERAPY. Tom Heaps Consultant Acute Physician
INTRAVENOUS FLUID THERAPY Tom Heaps Consultant Acute Physician LEARNING OBJECTIVES 1. Crystalloids vs colloids 2. Balanced vs non-balanced solutions 3. Composition of various IV fluids 4. What is normal
More information9 Diabetes care. Back to contents
Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Intravenous fluid therapy in adults in hospital Quality standard title: Intravenous fluid
More informationSuboptimal hydration harms patients.
Suboptimal hydration harms patients. NHS Fife is committed to improving hydration management. To achieve this we need your help! In 2014 new fluid balance charts were implemented in the Victoria Hospital,
More informationFluids and electrolytes: the basics
Fluids and electrolytes: the basics This document is based on the handout from the Surgery for Finals course. The notes provided here summarise key aspects, focusing on areas that are popular in clinical
More informationSuspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationPeri-operative management of the surgical patient with diabetes GL059
DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016
More informationStRs and CT doctors in haematology. September Folinic acid dose modified.
High dose Methotrexate and folinic acid rescue Full Title of Guideline: Author (include email and role): Division & Speciality: Clinical Guideline Review Date September 2018 GUIDELINE FOR THE USE OF HIGH
More informationTumour Lysis Syndrome (TLS)
(TLS) Overview: Tumour lysis syndrome refers to a number of metabolic disturbances (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) that occur as the result of rapid cell lysis. This
More informationSt Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24
St Helens & Knowsley Hospitals, 2014-16 Adult Inpatient Diabetes Management Guidelines St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines 2014-2016 v24 Title Adult Inpatient
More informationWith Dr. Sarah Reid and Dr. Sarah Curtis
5. Headaches 6. Known diabetes 7. Specific high risk groups (ie. Teenagers, children on insulin pumps and those from lower socio-economic status). Episode 63 Pediatric Diabetic Ketoacidosis With Dr. Sarah
More informationTable 1. Common precipitating events of DKA.
Update in Anaesthesia Diabetic ketoacidosis Claire Preedy and William English Correspondence Email: englishwilliam@hotmail.com DEFINITION Diabetes ketoacidosis (DKA) is a medical emergency. It is classified
More informationWritten Guidelines for Laboratory Testing in Intensive Care - Still Effective After 3 Years
Written Guidelines for Laboratory Testing in Intensive Care - Still Effective After 3 Years S. M. MEHARI, J. H. HAVILL Intensive Care Unit, Waikato Hospital, Hamilton, NEW ZEALAND ABSTRACT Objective: The
More informationPARENTERAL NUTRITION
PARENTERAL NUTRITION DEFINITION Parenteral nutrition [(PN) or total parenteral nutrition (TPN)] is the intravenous infusion of some or all nutrients for tissue maintenance, metabolic requirements and growth
More informationST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5
HEPARIN ANTICOAGULATION Page 1 of 5 Pharmacy Mnemonic: CRRTHEP1 PATIENT DATA: DIAGNOSIS: AKI ESRD Other: WEIGHT: Today: kg Admission Weight:: kg Dry Weight: kg Access TYPE: Temporary Dialysis Catheter
More informationGUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES
GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target
More informationIndex No: MMG11/1. Version: 1. Date ratified: 12 th November 2013
Index No: Intravenous fluid prescription in children For previously well children aged one month to 16 years (excluding renal, cardiac, diabetic ketoacidosis and acute burns patients) Version: 1 Date ratified:
More informationFluid assessment, monitoring and therapy for the acute nurse
Fluid assessment, monitoring and therapy for the acute nurse Kelly Wright Lead Nurse for AKI King s College Hospital Aims and objectives Aims and objectives Why do we worry about volume assessment? Completing
More informationThe changing face of
The changing face of sepsis. @SepsisUK Dr Ron Daniels B.E.M. CEO, UK Sepsis Trust CEO, Global Sepsis Alliance Special Adviser (maternal sepsis) to WHO Breast cancer Cognitive impairment Mild 3.8 7.1
More informationNHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults
NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults Co-ordinators: Medicines Information Pharmacist Consultation Group: See relevant page in guidance Approver: Medicine Guidelines
More informationCLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline 1.1. This guideline contains recommendations about general principles for managing intravenous (IV)
More informationDR J HARTY / DR CM RITCHIE / DR M GIBBONS
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Paracetamol Poisoning DR J HARTY / DR CM RITCHIE / DR M GIBBONS Medicine Acute Date Uploaded: 16 th September 2014 Review Date
More informationSepsis! Dr Eric Van Den Bergh Consultant in Emergency Medicine 2015
Sepsis! Dr Eric Van Den Bergh Consultant in Emergency Medicine 2015 Annual UK Mortality Sepsis Stroke Heart attack COPD Lung cancer COPD Heart attack Stroke Sepsis Lung cancer 0 10000 20000 30000 40000
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationDIABETIC KETOACIDOSIS
DIABETIC KETOACIDOSIS MODULE: ENDOCRINOLOGY / METABOLIC TARGET: ALL PAEDIATRIC TRAINEES; NURSING STAFF BACKGROUND: DKA occurs when a relative or absolute lack of insulin leads to the inability to metabolise
More informationPRE- EXISTING DIABETES GUIDELINE
Reference No. 242 PRE- EXISTING DIABETES GUIDELINE Lead Director: Medical Director, Family & Women s Health Group Author: Linda Wilkinson, Diabetes Specialist Nurse Dr Belinda Allen, Consultant Physician
More informationGESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
More informationPREOPERATIVE ANAEMIA PATHWAY
PREOPERATIVE ANAEMIA PATHWAY Surname: Unit No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: GP Name: GP Practice: Planned Operation: Postcode: Mobile
More informationTOO SWEET TOO STORMY. CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth. PRESENTOR: Dr. Abhinaya PG I (M.D Paeds)
TOO SWEET TOO STORMY PRESENTOR: Dr. Abhinaya PG I (M.D Paeds) CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth Unit IV, Dept. Of Paediatrics, SRMC & RI 14year old female complaints of
More informationNeonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist
CLINICAL GUIDELINES ID TAG Title: Author: Designation: Speciality / Division: Directorate: Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick
More informationDiabetes in pregnancy guideline (GL983)
Diabetes in pregnancy guideline (GL983) Approval Approval Group Job Title, Chair of Committee Date Maternity & Children s Services Clinical Governance Committee Chair, Maternity Clinical Governance Committee
More informationADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES
ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES DEFINITION -Glucose >250 mg/dl*, anion gap > 16, + ketones * Glucose < 250 does not exclude DKA especially if anion gap >
More informationGUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)
When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032
More informationTHe Story of salty Sam
THe Story of salty Sam Understanding fluids, urea and electrolyte balance; a quantitative approach. A self-directed learning activity. Part One. meet salty sam Salty Sam is a pretty average 70 kg bloke,
More informationDKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014
DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,
More informationElectrolytes by case examples. Graham Bilbrough, European Medical Affairs Manager
Electrolytes by case examples Graham Bilbrough, European Medical Affairs Manager 1 Acid-bases disturbances Generally result from one of the following: 1. damage to an organ such as the kidneys or lungs
More informationDeveloping a pathway of. and care planning for people with diabetes
Developing a pathway of preoperative assessment and care planning for people with diabetes Louise Hilton, Marie Digner Diabetes is a common endocrine condition affecting 1.4 million people in the UK, with
More informationBurns Management in the Emergency Department
Management in the Emergency Department (Referral Proforma) Time/Date of injury (24hr) Patient demographic data sticker Airway Please remember to protect C-spine until clinically cleared as stable Administer
More informationA case of severe hyperkalaemia presenting with cardiac arrythmias: An uncommon initial manifestation of chronic kidney disease
Case Report A case of severe hyperkalaemia presenting with cardiac arrythmias: An uncommon initial manifestation of chronic kidney disease D H Sudusinghe 1, J indrakumar 2 1 Department of Physiology, Faculty
More information